The National Accreditation Board for Hospitals & Healthcare Providers (NABH) and the Research Society for the Study of Diabetes in India (RSSDI) have partnered to enhance diabetes care in India, impacting over 250 million individuals. This collaboration will establish robust clinical and digital health standards, leading to improved patient outcomes and standardized treatment protocols nationwide.
The National Accreditation Board for Hospitals & Healthcare Providers (NABH) and the Research Society for the Study of Diabetes in India (RSSDI) have partnered to enhance diabetes care in India, impacting over 250 million individuals. This collaboration will establish robust clinical and digital health standards, leading to improved patient outcomes and standardized treatment protocols nationwide.
The National Accreditation Board for Hospitals & Healthcare Providers (NABH) and the Research Society for the Study of Diabetes in India (RSSDI) have partnered to enhance diabetes care in India, impacting over 250 million individuals. This collaboration will establish robust clinical and digital health standards, leading to improved patient outcomes and standardized treatment protocols nationwide.
Kilmarnock striker Bruce Anderson and former Celtic midfielder Scott Allan, both living with type 1 diabetes, discuss their inspiring journeys in football and how the condition hasn’t stopped them from achieving their dreams. Their story highlights the importance of support, perseverance, and managing the condition effectively to thrive in any field.
Doctors Without Borders (MSF) is calling for insulin manufacturers to sell injection pen devices at $1 per pen to ensure access to life-saving treatment for millions in low- and middle-income countries. The organization highlights the exorbitant prices set by major insulin producers, creating a global crisis in diabetes care.
Government-run generic pharmacies in India, known as Janaushadhi Kendras, have seen a surge in sales of medicines for lifestyle diseases like hypertension and diabetes. Telmisartan, atorvastatin, pantoprazole and domperidone, and glimepiride/metformin combinations are among the top-selling drugs, indicating a growing demand for affordable healthcare solutions. The program aims to increase the number of Kendras to 25,000 by 2026, making quality generic medicines accessible to a wider population.
Affidea, a leading European healthcare provider, has partnered with Reset Health to introduce the Roczen platform, a doctor-led digital solution for managing obesity and type 2 diabetes. Roczen combines personalized treatment plans, GLP-1 medications, and lifestyle changes to improve health outcomes for patients across Affidea’s network.
Chef Rohan Sehgal’s experiment on the impact of Diwali sweets on blood sugar levels has sparked conversation online, with some praising the informative value and others finding it unnecessary. The experiment, shared on Instagram, showed a moderate spike in blood sugar after consuming Boondi Laddoos, while other sweets took longer to return to normal levels. This has led to discussions about making informed choices during the festive season.
Eli Lilly has emerged as the world’s most valuable pharmaceutical company, driven by its innovative weight loss and diabetes drugs, Zepbound and Mounjaro. This article explores the factors behind Lilly’s impressive growth, its strategies to combat copycats, and its potential to maintain its leadership position in the industry.
Medtronic has issued a Class I recall for its MiniMed 600 and 700 insulin pumps due to potential battery life issues. The recall comes after reports of shortened battery life, possibly caused by drops or impacts. Medtronic advises users to closely monitor battery alerts and carry extra batteries as a precaution.
